Zentalis Pharmaceuticals, Inc. — All Filings
516 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
4
4/A
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
PRE 14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-K | 10-K | 0001725160-26-000014 | Mar 26, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001725160-26-000010 | Mar 26, 2026 | — |
| SCHEDULE 13G | — | 0002050709-26-000011 | Mar 3, 2026 | — |
| 4 | FORM 4 | 0001838041-26-000004 | Feb 10, 2026 | Feb 6, 2026 |
| 4 | FORM 4 | 0002018766-26-000006 | Feb 10, 2026 | Feb 6, 2026 |
| 4 | FORM 4 | 0001500189-26-000004 | Feb 10, 2026 | Feb 6, 2026 |
| 4 | FORM 4 | 0002018766-26-000004 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | FORM 4 | 0002018766-26-000002 | Jan 9, 2026 | Jan 8, 2026 |
| 4 | FORM 4 | 0001664928-26-000003 | Jan 9, 2026 | Jan 8, 2026 |
| 4 | FORM 4 | 0001838041-26-000002 | Jan 9, 2026 | Jan 8, 2026 |
| 4 | FORM 4 | 0001500189-26-000002 | Jan 9, 2026 | Jan 8, 2026 |
| 8-K | 8-K | 0001725160-26-000003 | Jan 9, 2026 | Jan 6, 2026 |
| 4 | — | 0001213900-26-002567 | Jan 8, 2026 | Dec 31, 2025 |
| 3 | OWNERSHIP DOCUMENT | 0001213900-26-002566 | Jan 8, 2026 | Dec 15, 2025 |
| SCHEDULE 13G/A | — | 0001213900-26-001456 | Jan 5, 2026 | — |
| SCHEDULE 13D/A | — | 0000902664-26-000024 | Jan 2, 2026 | — |
| SCHEDULE 13G | — | 0001873515-25-000004 | Dec 30, 2025 | — |
| 4 | — | 0000902664-25-005288 | Dec 15, 2025 | — |
| SCHEDULE 13D/A | — | 0000902664-25-005287 | Dec 15, 2025 | — |
| 8-K | 8-K | 0001725160-25-000164 | Dec 15, 2025 | — |
| 10-Q | 10-Q | 0001725160-25-000161 | Nov 10, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001725160-25-000159 | Nov 10, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-099251 | Oct 14, 2025 | — |
| 4 | FORM 4 | 0001664928-25-000008 | Oct 1, 2025 | — |
| 3 | FORM 3 | 0001664928-25-000006 | Sep 22, 2025 | Sep 18, 2025 |
| 8-K | 8-K | 0001725160-25-000154 | Aug 26, 2025 | — |
| 10-Q | 10-Q | 0001725160-25-000149 | Aug 6, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0001725160-25-000147 | Aug 6, 2025 | — |
| SCHEDULE 13G/A | — | 0002052113-25-002526 | Jul 16, 2025 | — |
| 4 | FORM 4 | 0001725160-25-000137 | Jun 18, 2025 | Jun 17, 2025 |
| 4 | FORM 4 | 0001725160-25-000135 | Jun 18, 2025 | Jun 17, 2025 |
| 4 | FORM 4 | 0001725160-25-000133 | Jun 18, 2025 | Jun 17, 2025 |
| 4 | FORM 4 | 0001725160-25-000131 | Jun 18, 2025 | Jun 17, 2025 |
| 4 | FORM 4 | 0001725160-25-000129 | Jun 18, 2025 | Jun 17, 2025 |
| 8-K | 8-K | 0001725160-25-000127 | Jun 18, 2025 | Jun 17, 2025 |
| 8-K | 8-K | 0001725160-25-000119 | Jun 2, 2025 | May 31, 2025 |
| DEFA14A | DEFA14A | 0001725160-25-000112 | May 23, 2025 | — |
| 8-K | 8-K | 0001725160-25-000108 | May 20, 2025 | — |
| S-8 | S-8 | 0001725160-25-000106 | May 14, 2025 | — |
| 10-Q | 10-Q | 0001725160-25-000105 | May 14, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0001725160-25-000104 | May 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001580642-25-003116 | May 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001580642-25-003101 | May 13, 2025 | — |
| 4 | FORM 4 | 0001725160-25-000094 | Apr 30, 2025 | — |
| DEFA14A | DEFA14A | 0001725160-25-000093 | Apr 30, 2025 | — |
| DEF 14A | DEF 14A | 0001725160-25-000092 | Apr 30, 2025 | Jun 17, 2025 |
| ARS | ARS | 0001725160-25-000091 | Apr 30, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0001725160-25-000082 | Apr 28, 2025 | Apr 27, 2025 |
| EFFECT | — | 9999999995-25-000989 | Apr 4, 2025 | — |
| CORRESP | — | 0001725160-25-000073 | Apr 2, 2025 | — |